abstract |
A cat vaccine formula including at least three polynucleotide vaccine valencies that each include a plasmid containing a cat pathogen valency gene capable of being expressed in vivo in host cells. Said valencies are selected from the group which consists of feline leukaemia virus, panleukopenia virus, infectious peritonitis virus, coryza virus, calicivirus disease virus, feline immunodeficiency virus and optionally rabies virus. Said plasmids include one or more genes per valency, and said genes are selected from the group which consists of env and gag for feline leukaemia, VP2 for panleukopenia, modified S, M and N for infectious peritonitis, gB and gD for coryza, capsid for calicivirus disease, env and gag/pro for feline immunodeficiency and G for rabies. |